Page last updated: 2024-08-17

cytidine and Disease Exacerbation

cytidine has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Babudieri, S; Bacciu, S; Bitti, A; Colpani, A; De Vito, A; Denti, L; Fois, M; Madeddu, G; Maida, I; Marcia, C; Meloni, MC; Zauli, B1
Au, ICH; Cowling, BJ; Lau, EHY; Lau, KTK; Leung, GM; Wong, CKH1
Chen, Z; Dai, Q; Li, J; Lu, Z; Luo, G; Qi, M; Shen, B; Wang, H; Wu, Y; Zheng, Z1

Other Studies

3 other study(ies) available for cytidine and Disease Exacerbation

ArticleYear
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience.
    Journal of medical virology, 2022, Volume: 94, Issue:11

    Topics: Aged; Aged, 80 and over; COVID-19 Drug Treatment; Cytidine; Disease Progression; Humans; Hydroxylamines; Middle Aged; Retrospective Studies; SARS-CoV-2

2022
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: a
    Lancet (London, England), 2022, 10-08, Volume: 400, Issue:10359

    Topics: Antiviral Agents; COVID-19 Drug Treatment; Cytidine; Disease Progression; Hong Kong; Hospital Mortality; Hospitalization; Humans; Hydroxylamines; Independent Living; Retrospective Studies; Ritonavir; SARS-CoV-2

2022
Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs.
    Nucleic acids research, 2019, 03-18, Volume: 47, Issue:5

    Topics: Adenosine; AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cytidine; Disease Progression; HeLa Cells; Humans; Mice; Neoplasm Invasiveness; Neoplasms; Ribonuclease, Pancreatic; RNA, Transfer; Xenograft Model Antitumor Assays

2019